9th Annual Biotech Showcase 2017

Santa Monica, CA, 4 January 2017 – Trethera, a biotechnology company focused on the discovery and development of innovative small molecules for the treatment of hematological and solid tumors will be attending Biotech Showcase 2017, San Francisco, USA, 9th-11th January 2017. The Company’s targeted metabolic pathway therapy approach involves using a rationally-designed combination of two or three drugs from the very start of cancer treatment.

For more information on Trethera’s presentations or for media enquiries, please contact trethera@instinctif.com.